Indication

Prolactin-Producing Pituitary Tumor

1 clinical trial

1 product

Clinical trial

Pasireotide Treatment for Patients With Prolactinomas Who Need Treatment Beyond Dopamine Agonist Therapy

Status: Recruiting, Estimated PCD: 2027-02-01

Product